MDXGMiMedx Group, Inc.

$666M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M-29.3% YoY

Gross Profit

$58M85.5% margin

Operating Income

-$17M-25.3% margin

Net Income

-$17M-25.5% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+1.3%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$170M

Total Liabilities

$146M

Stockholders' Equity

$25M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$95M	-29.3%
Gross Profit	$58M	$86M	-33.0%
Operating Income	-$17M	$2M	-1119.3%
Net Income	-$17M	$2M	-1054.0%

MDXG Q2 2019 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena